Pressroom: Media Coverage

Showing 561 - 580 of 598 news items

2011

Pleasantville's Sabety Beats Cancer with Music

Cancer survivor Ted Sabety discusses his battle with cancer at the Memorial Sloan Kettering Cancer Center Survivorship Dinner in Sleepy Hollow, NY.

June 14, 2011
Retinoblastoma Therapy Delivers Power of Chemotherapy with Surgical Precision

The past century has seen great strides in the treatment of retinoblastoma, with more than 95 percent of US patients now being cured of this rare childhood malignancy. Ophthalmic oncologist David Abramson is quoted.

June 8, 2011
Taking Chemo Drug Continuously Delayed Lung Cancer's Return

While most patients with advanced lung cancer take four courses of two chemotherapy drugs and then stop until recurrence occurs, continuing treatment with one of those drugs may delay return of the disease. Medical oncologist Mark Kris is quoted.

June 5, 2011
Study: Flaxseed Doesn't Reduce Women's Hot Flashes

A phase III trial showed that flaxseed did not significantly reduce hot flashes in postmenopausal women with or without breast cancer. Medical oncologist Mark Kris is quoted.

June 5, 2011
Roche's Avastin Shows Ovarian Cancer Benefit

A study led by gynecologic oncologist Carol Aghajanian showed the drug bevacizumab (Avastin®) delayed the progression of advanced ovarian cancer. She is quoted in the article.

June 5, 2011
Melanoma Drug Extends Life in Second Large Study

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Studies Find New Drugs Boost Skin Cancer Survival

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Two Drugs Shown to Prolong Survival in Advanced Melanoma Cases

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Drug Dramatically Helps Melanoma Patients

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Drugs Show Promise Slowing Advanced Melanoma

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Removing a Brain Tumor

Neurosurgeon Philip Gutin discusses one of his recent brain surgery cases.

June 5, 2011
Best Doctors 2011

Seventy-one doctors from Memorial Sloan Kettering Cancer Center were listed among New York Magazine’s 2011 Best Doctors list.

June 5, 2011
Matching Cancer Drugs to Gene Mutations Raises Survival Odds

Doctors are treating cancer according to the genetic aberrations found in patients’ tumors, not just where they’re found in the body, an approach that may boost the odds of survival. Medical oncologist Leonard Saltz is quoted.

June 4, 2011
Cancer Cell Tests May Help Predict Drug Reaction

Two studies led by researchers at Memorial Sloan Kettering Cancer Center are part of the search for biological signals known as biomarkers that can predict which patients are the best match for drugs or give an early indication that treatments are working. Medical oncologists Howard Scher and Mark Kris are quoted.

June 4, 2011
Aromasin Cuts Risk of Breast Cancer in Some Groups

The estrogen-blocker exemestane (Aromasin®) was found to reduce the risk of developing breast cancer by 65 percent in postmenopausal women at high risk for breast cancer. Medical oncologist Andrew Seidman is quoted.

June 4, 2011
Roche's Avastin Delays Death by Slowing Growth of Ovarian Cancer

A study led by gynecologic oncologist Carol Aghajanian showed the drug bevacizumab (Avastin®) delayed the progression of advanced ovarian cancer. She is quoted in the article.

June 4, 2011
Woodbridge Man Celebrates Life After Cancer

A celebration was held at Memorial Sloan Kettering Cancer Center Basking Ridge to honor cancer survivors treated at the Center’s outpatient facility in New Jersey. Medical oncologist Han Xiao is quoted.

June 3, 2011
Scanxiety

Psycho-oncologist Jimmie Holland is quoted in an article about “scanxiety,” the stress that some cancer patients experience as their scan appointments approach.

June 2, 2011
CBS Evening News

Medical oncologist Eileen O’Reilly discusses how medical professionals can improve their communication with patients regarding end-of-life issues.

June 1, 2011
MSKCC Gets Nod For Eco-Practices

A “green team” from Memorial Sloan Kettering Cancer Center has spent the past two years developing ways for the hospital, with more than 11,000 employees in 40 locations, to become more energy efficient and reduce its waste. Hospital administrator Cynthia McCollum is quoted.

May 31, 2011